A detailed history of Canada Pension Plan Investment Board transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 395,100 shares of BMRN stock, worth $26.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
395,100
Previous 240,516 64.27%
Holding current value
$26.2 Million
Previous $19.8 Million 40.25%
% of portfolio
0.03%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$69.02 - $93.84 $10.7 Million - $14.5 Million
154,584 Added 64.27%
395,100 $27.8 Million
Q2 2024

Aug 12, 2024

SELL
$74.43 - $92.22 $5.37 Million - $6.65 Million
-72,122 Reduced 23.07%
240,516 $19.8 Million
Q1 2024

May 14, 2024

BUY
$83.81 - $99.0 $2.92 Million - $3.45 Million
34,867 Added 12.55%
312,638 $27.3 Million
Q4 2023

Feb 14, 2024

BUY
$76.22 - $98.51 $1.31 Million - $1.69 Million
17,200 Added 6.6%
277,771 $26.8 Million
Q3 2023

Nov 09, 2023

SELL
$85.07 - $94.48 $136,112 - $151,168
-1,600 Reduced 0.61%
260,571 $23.1 Million
Q2 2023

Aug 09, 2023

SELL
$86.68 - $100.3 $5.01 Million - $5.8 Million
-57,800 Reduced 18.06%
262,171 $22.7 Million
Q1 2023

May 12, 2023

BUY
$87.74 - $117.27 $2.96 Million - $3.96 Million
33,750 Added 11.79%
319,971 $31.1 Million
Q4 2022

Feb 14, 2023

BUY
$80.93 - $108.63 $4.85 Million - $6.51 Million
59,900 Added 26.47%
286,221 $29.6 Million
Q3 2022

Nov 14, 2022

BUY
$82.16 - $96.94 $2.4 Million - $2.83 Million
29,197 Added 14.81%
226,321 $19.2 Million
Q2 2022

Aug 12, 2022

BUY
$71.48 - $86.85 $12.8 Million - $15.6 Million
179,500 Added 1018.5%
197,124 $16.3 Million
Q1 2022

May 13, 2022

SELL
$74.28 - $92.69 $2.47 Million - $3.08 Million
-33,187 Reduced 65.31%
17,624 $1.36 Million
Q4 2021

Feb 14, 2022

SELL
$71.72 - $91.47 $6.29 Million - $8.03 Million
-87,735 Reduced 63.33%
50,811 $4.49 Million
Q2 2021

Aug 16, 2021

SELL
$75.51 - $84.79 $5.31 Million - $5.96 Million
-70,261 Reduced 33.65%
138,546 $11.6 Million
Q1 2021

May 17, 2021

BUY
$74.73 - $90.69 $11 Million - $13.4 Million
147,827 Added 242.42%
208,807 $15.8 Million
Q4 2020

Feb 17, 2021

SELL
$72.61 - $90.2 $782,517 - $972,085
-10,777 Reduced 15.02%
60,980 $5.35 Million
Q3 2020

Nov 12, 2020

SELL
$71.87 - $131.03 $12.6 Million - $22.9 Million
-174,717 Reduced 70.89%
71,757 $5.46 Million
Q2 2020

Aug 14, 2020

BUY
$79.55 - $124.22 $2.22 Million - $3.46 Million
27,871 Added 12.75%
246,474 $30.4 Million
Q1 2020

May 13, 2020

SELL
$71.37 - $96.85 $6.54 Million - $8.88 Million
-91,651 Reduced 29.54%
218,603 $18.5 Million
Q4 2019

Feb 14, 2020

SELL
$64.27 - $86.37 $6.94 Million - $9.33 Million
-108,010 Reduced 25.82%
310,254 $26.2 Million
Q3 2019

Nov 12, 2019

SELL
$67.4 - $85.11 $12.3 Million - $15.6 Million
-183,009 Reduced 30.44%
418,264 $28.2 Million
Q2 2019

Aug 12, 2019

BUY
$80.35 - $93.9 $2.31 Million - $2.7 Million
28,715 Added 5.02%
601,273 $51.5 Million
Q1 2019

May 15, 2019

BUY
$84.2 - $98.62 $14.6 Million - $17.1 Million
173,648 Added 43.53%
572,558 $50.9 Million
Q4 2018

Feb 06, 2019

BUY
$80.14 - $106.07 $4.66 Million - $6.17 Million
58,144 Added 17.06%
398,910 $34 Million
Q3 2018

Nov 09, 2018

SELL
$93.92 - $105.72 $8.19 Million - $9.22 Million
-87,233 Reduced 20.38%
340,766 $33 Million
Q2 2018

Aug 07, 2018

BUY
$76.01 - $99.03 $13.2 Million - $17.2 Million
173,850 Added 68.4%
427,999 $40.3 Million
Q1 2018

May 14, 2018

BUY
$77.67 - $92.63 $12.1 Million - $14.4 Million
155,900 Added 158.68%
254,149 $20.6 Million
Q4 2017

Feb 14, 2018

BUY
$80.76 - $95.13 $3.11 Million - $3.66 Million
38,500 Added 64.44%
98,249 $8.76 Million
Q3 2017

Oct 30, 2017

SELL
$80.6 - $94.95 $6.31 Million - $7.44 Million
-78,326 Reduced 56.73%
59,749 $5.56 Million
Q2 2017

Jan 31, 2018

BUY
N/A
65,939 Added 91.41%
138,075 $12.5 Million
Q1 2017

Jan 31, 2018

BUY
N/A
72,136
72,136 $6.33 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.3B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.